When I was serving as a department chair and working in operational leadership at a large medical foundation, we undertook an experiment in “lean management”. The goal was simple: identify waste by asking what a patient actually values.
While examining a young boy with esotropia, I turned to his father and asked: “Of everything involved in your family’s journey to see me here today, what is the one thing you would actually want to pay for if you had a choice?“
Without hesitating, he said it three times: “Time with you, Doc.“
That moment stayed with me. It wasn’t the administrative processes, the coordination layers, or the elaborate machinery surrounding healthcare that mattered most to him—it was uninterrupted time between doctor and patient.
The Sensitive Period
In pediatric ophthalmology, time carries an even deeper meaning. From my early days in neuroscience at Brown studying under Prof. Michael Paradiso, I learned about the “sensitive period” of visual development. In a child’s growth, there are developmental windows that, once passed, do not return. Time is truly our most critical resource.
Moving Beyond RVUs: The Paradox of Efficiency in Healthcare
Yet, the traditional productivity-driven healthcare model often creates a paradox: the more efficient you try to be, the more patients you are expected to squeeze into fixed units of time, reducing the very thing families value most.
Three years ago, I chose a different path. I left that system to build a practice focused on relationships and dedicated time rather than externally imposed fee schedules and volume.
Rethinking Amblyopia Treatment: the Origins of Wondersee
Gaining that time allowed us to focus on a problem I had wanted to solve for years: amblyopia treatment. While we prescribe patching, most treatment occurs outside the clinic where we cannot observe it. To help parents ensure treatment happens during a child’s sensitive period, we developed an amblyopia occlusion dose monitor.
With the partnership of patient families, child volunteers, philanthropic support, and our team at Edge Eye Labs Inc., that initial research device has grown. Inspired by a nine-year-old patient who told me her research device helped her weak eye “Wondersee,” we were recently awarded a multi-million-dollar grant from the National Eye Institute (NEI) that directly accelerates our clinical testing and helps us bring Wondersee to families faster for the children who need it.
A Shared Vision: Reflections from a Road Less Traveled
At the recent American Academy of Ophthalmology (AAO) Pediatric Ophthalmology Subspecialty Day in New Orleans, I had the good fortune of sharing this journey alongside colleagues like Dr. Doug Frederick, Dr. Lakshmi Swamy, Dr. Greg Ostrow, and Dr. Michael F. Chiang.
What started with a father’s earnest reply about time has become a community-driven response to pull into focus a sharper future for childhood vision.
